PetArmor® Provides Ultimate Protection To Police Dogs Across The Nation With Bullet And Stab Protective Vest Donation
OMAHA, Neb., Sept. 20, 2013 /PRNewswire/ -- PetArmor®, known for its veterinarian-quality products that protect dogs and cats from fleas and ticks, is now also helping to protect four legged K-9s in the line of duty.
As part of a yearlong partnership with Vested Interest in K-9s, PetArmor®, is providing funding for bullet and stab protective vests for law enforcement K-9s in Texas, Florida and Maryland.
"My Patrol K-9 Unit assists patrol officers with apprehensions and searches and evidence. We also assist the SWAT Team and various other units throughout the department," said Austin Police Department Sergeant Chris Gwaldo. "We are thrilled that – thanks to PetArmor® – our entire patrol unit will be more fully protected while on the job."
More often than not, law enforcement agencies do not have the budgets to provide vests for K-9 officers -- which cost around $1,000 each -- leaving police dogs unprotected while helping to fight crime. Vested Interest in K-9s is a non-profit organization dedicated to providing bullet and stab protective vests to police organizations nationwide. Since 2009, the non-profit organization has provided 437 vests.
"Police K-9 units provide an invaluable service to their community and deserve the same kind of protection as their human counterparts," said Sandy Marcal, founder of Vested Interest in K-9s, Inc. "Thanks to PetArmor®, many more police dogs will be protected from harm while they protect their neighborhoods and towns."
The K-9 vests are custom sized to provide maximum comfort and mobility. The K-9 vests provide maximum coverage to the vital organs in addition to a rear extension panel to accommodate dogs with longer torsos.
PetArmor's® initial donation benefits dogs at police departments, which have requested assistance in vesting their police dogs. "As a leader in pet protection, PetArmor® is excited to partner with Vested Interest in K-9s and protect the dogs that put their lives on the line to protect us," said Bob Scharf of Perrigo Animal Health. "This partnership is a continuation of PetArmor's® ongoing animal welfare and charity efforts."
About Vested Interest in K-9s, Inc.
Vested Interest in K-9s, Inc. is a 501c (3) all volunteer charity located in East Taunton, MA. whose mission is to provide bullet and stab protective vests for law enforcement dogs throughout the United States. The nonprofit was established in 2009 to assist law enforcement agencies with this potentially lifesaving body armor for their four legged K-9 Officers. President Sandy Marcal began working with law enforcement agencies in 2000 to coordinate efforts between various law enforcement agencies, vest sponsorships, fundraising events and the media within Massachusetts. In 2011, efforts were expanded to assist police dogs throughout the United States. For more information or to learn about volunteer opportunities, please call 508-824-6978. Tax deductible donations and event listings are via the website: www.vik9s.org.
As a part of the Perrigo Company, a leading global manufacturer of OTC healthcare products, PetArmor® products help improve the overall health of pets across the United States by providing vet-quality products that are affordable and accessible. PetArmor® flea and tick products contain fipronil, the No.1 veterinarian active ingredient for killing adult fleas and ticks. PetArmor® products offer clinically proven effectiveness at about half the price of comparable brand name treatments and are available at major national retailers. For more information, please visit http://www.petarmor.com/.
From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare products. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements and active pharmaceutical ingredients (API). The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The company's primary markets and locations of logistics operations have evolved over the years to include the United States, Israel, Mexico, the United Kingdom, India, China and Australia. Visit Perrigo on the Internet at www.perrigo.com.
Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 30, 2012, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise